Delivery Order SPE2DB25D3012-SPE2DB25FXANK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $38,472.49 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packages) under a firm fixed-price contract type. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-competitive delivery order against an existing contract vehicle. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,964.90 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on July 17, 2025, with completion scheduled for July 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,013.24 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packaging) on June 9, 2025, with a completion date of June 10, 2025. This firm fixed-price, non-set-aside delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $13,143.67 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing under a delivery order contract type and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The...
- The Defense Logistics Agency awarded a $16,591.33 delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. Performance will be executed from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,013.24 on July 25, 2025, for the supply of Sprycel 100 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and specifies a completion date of July 28, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,430.48 to AmerisourceBergen Drug Corp for the supply of Sprycel 70 mg tablets (60-count units). This firm fixed-price delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a direct pharmaceutical procurement under a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,854.78 on September 15, 2025, for the supply of Sprycel 100 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is non-set-aside and is scheduled for completion by September 16, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency awarded a $5,665.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) with a ceiling value of $41,700.72. This firm fixed-price delivery order, awarded on August 28, 2025, represents a non-competitive, non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. As a child contract, this delivery order...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXANKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,304.15 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's substantial $999.99 billion IDC with DLA Troop Support Medical (contract number SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and broader government healthcare requirements. Sprycel, a specialty oncology medication, aligns with the company's demonstrated capability to deliver specialized pharmaceutical products through the DLA Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 9/26/25 |